In Vitro Activities of Tigecycline (GAR-936) against Recently Isolated Clinical Bacteria in Spain-Reference-Cited by-同舟云学术

In Vitro Activities of Tigecycline (GAR-936) against Recently Isolated Clinical Bacteria in Spain

Published:2002-03 Issue:3 Volume:46 Page:892-895
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Betriu Carmen¹,Rodríguez-Avial Iciar¹,Sánchez Blas Ali¹,Gómez María¹,Álvarez Juan²,Picazo Juan J.¹

Affiliation:

1. Department of Clinical Microbiology, Hospital Clínico San Carlos

2. Scientific Department, Wyeth Farma, Madrid, Spain

Abstract

ABSTRACT The antimicrobial activities of tigecycline (GAR-936) were compared with those of other agents against 1,087 strains recently isolated in 12 Spanish medical centers. Tigecycline showed activity against a wide spectrum of aerobic and anaerobic bacteria, including strains such as methicillin-resistant Staphylococcus aureus , coagulase-negative staphylococci, penicillin-resistant Streptococcus pneumoniae , Enterococcus faecium , Acinetobacter baumannii , and Stenotrophomonas maltophilia.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.46.3.892-895.2002

Reference21 articles.

1. Multicenter Survey of the Changing In Vitro Antimicrobial Susceptibilities of Clinical Isolates of Bacteroides fragilis Group, Prevotella, Fusobacterium, Porphyromonas , and Peptostreptococcus Species

2. Betriu, C., C. Cabronero, M. Gomez, and J. Picazo. 1992. Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents 1979-1989. Eur. J. Clin. Microbiol. Infect. Dis.11:352-356.

3. In Vitro Activities of the Glycylcycline GAR-936 against Gram-Positive Bacteria

4. Chen, D. K., A. McGeer, J. C. de Azavedo, and D. E. Low. 1999. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N. Engl. J. Med.341:233-239.

5. Edlund, C., and C. Nord. 2000. In-vitro susceptibility of anaerobic bacteria to GAR-936, a new glycylcycline. Clin. Microbiol. Infect.6:159-163.

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global prevalence and distribution of antibiotic resistance among clinical isolates of Stenotrophomonas maltophilia: A systematic review and meta-analysis;Journal of Global Antimicrobial Resistance;2023-09

2. Evaluation of combination therapies with colistin in an experimental mouse pneumonia model induced by carbapenem‐resistant Acinetobacter baumannii strain;Fundamental & Clinical Pharmacology;2023-03-17

3. In Vitro Susceptibility of Tigecycline and Colistin Against Stenotrophomonas maltophilia;Flora the Journal of Infectious Diseases and Clinical Microbiology;2018-03-01

4. Antimicrobial susceptibility among important pathogens collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) in Spain, 2004–2014;Journal of Global Antimicrobial Resistance;2016-09

5. The efficacy of thuricin CD, tigecycline, vancomycin, teicoplanin, rifampicin and nitazoxanide, independently and in paired combinations against Clostridium difficile biofilms and planktonic cells;Gut Pathogens;2016-06-02